PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 18547105-7 2008 We conclude that glycosaminoglycans in the extracellular matrix have the capacity to promote coacervation at low concentrations of tropoelastin. Glycosaminoglycans 17-35 elastin Homo sapiens 131-143 17206488-7 2007 Organization of elastin and collagen in engineered arteries may have been partially hindered by high concentrations of sulfated glycosaminoglycans. Glycosaminoglycans 128-146 elastin Homo sapiens 16-23 12834595-0 2003 Preparation and evaluation of molecularly-defined collagen-elastin-glycosaminoglycan scaffolds for tissue engineering. Glycosaminoglycans 67-84 elastin Homo sapiens 59-66 12834595-2 2003 In this study, isolated type I collagen fibrils, elastin fibres and chondroitin sulphate (CS) were used for the preparation of molecularly-defined collagen-elastin-glycosaminoglycan scaffolds. Glycosaminoglycans 164-181 elastin Homo sapiens 49-56 12834595-2 2003 In this study, isolated type I collagen fibrils, elastin fibres and chondroitin sulphate (CS) were used for the preparation of molecularly-defined collagen-elastin-glycosaminoglycan scaffolds. Glycosaminoglycans 164-181 elastin Homo sapiens 156-163 9067256-7 1996 Glycosaminoglycans such as chondroitin sulfate, dermatan sulfate and a chondroitin polysulfate, interacted with myeloblastin as non-essential activators in the presence of peptide substrates (activation up to a 6.7-fold factor) and as partial inhibitors (about 50% inhibition at saturation) in the presence of elastin. Glycosaminoglycans 0-18 elastin Homo sapiens 310-317 10419484-7 1999 A testable model for elastin-glycosaminoglycan interactions is proposed, where tropoelastin deposition during elastogenesis is encouraged by local exposure to matrix glycosaminoglycans. Glycosaminoglycans 29-46 elastin Homo sapiens 21-28 10419484-7 1999 A testable model for elastin-glycosaminoglycan interactions is proposed, where tropoelastin deposition during elastogenesis is encouraged by local exposure to matrix glycosaminoglycans. Glycosaminoglycans 29-46 elastin Homo sapiens 79-91 10419484-7 1999 A testable model for elastin-glycosaminoglycan interactions is proposed, where tropoelastin deposition during elastogenesis is encouraged by local exposure to matrix glycosaminoglycans. Glycosaminoglycans 166-184 elastin Homo sapiens 21-28 10419484-7 1999 A testable model for elastin-glycosaminoglycan interactions is proposed, where tropoelastin deposition during elastogenesis is encouraged by local exposure to matrix glycosaminoglycans. Glycosaminoglycans 166-184 elastin Homo sapiens 79-91 10419484-9 1999 Following lysyl oxidase modification of tropoelastin lysine residues, they are released from glycosaminoglycan interactions, thereby permitting those residues to contribute to elastin cross-links. Glycosaminoglycans 93-110 elastin Homo sapiens 40-52 10419484-9 1999 Following lysyl oxidase modification of tropoelastin lysine residues, they are released from glycosaminoglycan interactions, thereby permitting those residues to contribute to elastin cross-links. Glycosaminoglycans 93-110 elastin Homo sapiens 45-52 8879521-0 1996 New preparation and microstructure of the EndoPatch elastin-collagen containing glycosaminoglycans. Glycosaminoglycans 80-98 elastin Homo sapiens 52-59 7899138-11 1994 We synthesized N-oleoyl heparin derivative (3 oleoyl groups/one molecule of heparin); such a lipophilic glycosaminoglycan (LipoGAG), although acting as an elastin protecting agent, possessed lower HNE inhibitory capacity as compared with heparin. Glycosaminoglycans 104-121 elastin Homo sapiens 155-162 7995378-9 1994 Elastin was also found associated with glycosaminoglycans in the soluble matrix of the aortic wall. Glycosaminoglycans 39-57 elastin Homo sapiens 0-7 35620518-7 2022 On the other hand, ELN shows promising attributes as a biomarker in adolescent and adult Morquio A. Plasma/urine keratan sulfate (KS), and urinary glycosaminoglycan (GAG) levels were significantly higher in Morquio A patients (p < 0.001) which decreased with age of patients. Glycosaminoglycans 147-164 elastin Homo sapiens 19-22 2127920-1 1990 Appreciable amounts of glycosaminoglycans have been found by immunocytochemistry within mature elastin fibers of human dermis. Glycosaminoglycans 23-41 elastin Homo sapiens 95-102 35620518-7 2022 On the other hand, ELN shows promising attributes as a biomarker in adolescent and adult Morquio A. Plasma/urine keratan sulfate (KS), and urinary glycosaminoglycan (GAG) levels were significantly higher in Morquio A patients (p < 0.001) which decreased with age of patients. Glycosaminoglycans 166-169 elastin Homo sapiens 19-22 3816142-5 1986 On the contrary, in the aortas of both patients collagen fibrils were significantly smaller than in the controls; moreover, elastin lamellae were deeply altered and consisted of roundish aggregates of elastin, massively permeated by cytochemically recognizable glycosaminoglycans. Glycosaminoglycans 261-279 elastin Homo sapiens 124-131 20939056-3 2010 To overcome this problem, glycosaminoglycans were coblended with tropoelastin during the formation of synthetic elastin hydrogels. Glycosaminoglycans 26-44 elastin Homo sapiens 70-77 13572631-0 1958 [Possible relation between mucopolysaccharides (hexosamine) and protein part in elastin]. Glycosaminoglycans 27-46 elastin Homo sapiens 80-87 24945362-2 2017 We report that the content of insoluble elastin in the dermis of cultured human skin can be increased though the use of two approaches that enhance elastogenesis by dermal fibroblasts, forced expression of versican variant V3, which lacks glycosaminoglycan (GAG) chains, and forced expression of versican antisense to decrease levels of versican variant V1 with GAG chains. Glycosaminoglycans 239-256 elastin Homo sapiens 40-47 24945362-2 2017 We report that the content of insoluble elastin in the dermis of cultured human skin can be increased though the use of two approaches that enhance elastogenesis by dermal fibroblasts, forced expression of versican variant V3, which lacks glycosaminoglycan (GAG) chains, and forced expression of versican antisense to decrease levels of versican variant V1 with GAG chains. Glycosaminoglycans 258-261 elastin Homo sapiens 40-47 24945362-2 2017 We report that the content of insoluble elastin in the dermis of cultured human skin can be increased though the use of two approaches that enhance elastogenesis by dermal fibroblasts, forced expression of versican variant V3, which lacks glycosaminoglycan (GAG) chains, and forced expression of versican antisense to decrease levels of versican variant V1 with GAG chains. Glycosaminoglycans 362-365 elastin Homo sapiens 40-47 26151781-2 2015 As a group, the glycosaminoglycans provide mechanical strength to skin, as they can absorb water and occupy the space between elastin fibers and collagen. Glycosaminoglycans 16-34 elastin Homo sapiens 126-133 24497431-4 2014 Results demonstrated that a resilient, hydrophilic hydrogel which displays a unique "shape-memory" sponge characteristic could be formed from a blend of soluble elastin aggregates, chondroitin-6-sulfate, hyaluronic acid and collagen following freeze-drying, stabilization with a carbodiimide and penta-galloyl glucose-based fixative, and subsequent partial degradation with glycosaminoglycan degrading enzymes. Glycosaminoglycans 374-391 elastin Homo sapiens 161-168 23261552-7 2013 In addition, elastin could stimulate cryopreserved chondrocytes to synthesize more glycosaminoglycans and collagen than poly-L-lysine. Glycosaminoglycans 83-101 elastin Homo sapiens 13-20 19895887-8 2010 This biochemistry models glycosaminoglycan interactions on the cell surface during elastogenesis which is characterized by the clustering of nascent tropoelastin aggregates to form micron-sized spherules. Glycosaminoglycans 25-42 elastin Homo sapiens 149-161